c-LEcta GmbH
Dr. Michael Dirkmann has work experience as a Head of Quality Control at c-LEcta GmbH since March 2022. Prior to that, they were a Project Manager at the same company from November 2018 to March 2022. Dr. Michael also worked as a Wissenschaftlicher Mitarbeiter (Postdoktorand) at Universität Bochum from February 2018 to October 2018, and as a PHD Student at Ruhr-Universität Bochum from November 2013 to February 2018.
Dr. Michael Dirkmann obtained their Bachelor of Science in Chemische Biologie from TU Dortmund University, where they studied from 2008 to 2011. Dr. Michael furthered their education at the same institution and earned a Master of Science in Chemische Biologie from 2011 to 2013.
This person is not in the org chart
c-LEcta GmbH
c-LEcta operates as a biotechnology company focusing on enzyme engineering and bioprocess development for regulated markets such as food and pharmaceutical. It develops, manufactures, and commercializes application-oriented enzyme variants either as its own product or in cooperative development with industry partners. c-LEcta offers DENARASE, agenetically engineered endonuclease used in biotechnology for the quantitative removal of nucleic acids and viscosity reduction; and CalB Immo Plus, a hydrophobic immobilized CalB preparation. Marc Struhalla and Thomas Greiner-Stöffele founded it in 2004, with its headquarters in Leipzig in Germany.